Shares in Wegovy-maker Novo Nordisk pop 7% after GLP-1 pill approval
Neutral
0.0
The FDA on Monday approved the first-ever GLP-1 pill from the Danish pharmaceutical giant.
Pulse AI Analysis
Pulse analysis not available yet. Click "Get Pulse" above.
This analysis was generated using Pulse AI, Glideslope's proprietary AI engine designed to interpret market sentiment and economic signals. Results are for informational purposes only and do not constitute financial advice.
